gasseri was cultured in vitro to assess the impact of QCHS on its growth
Cuartero MI, Garca Culebras A, Nieto-Vaquero C, Fraga E, Torres Lpez C, Pradillo J
Only through interdisciplinary collaboration, open science, and technology-driven democratization of care can the field transition from symptomatic palliation to genuine disease modification (Table 4)
If a clinic or wellness facility markets BPC-157 as FDA-Approved, they are engaged in illegal misbranding
If the treatment causes a detrimental shift in microbial composition, leading to adverse effects like gastrointestinal distress or immune suppression, healthcare providers could intervene by adjusting the treatment regimen or introducing probiotic interventions to restore microbial balance